Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_assertion description "[These results suggest that GATA1 transcriptionally upregulates cytidine deaminase and that the presence or absence of GATA1 mutations in AML blasts likely confers differences in ara-C sensitivities due to effects on cytidine deaminase gene expression, which, in turn, contributes to the high cure rate of Down syndrome AMkL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_assertion evidence source_evidence_literature NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_assertion SIO_000772 15687366 NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_assertion wasDerivedFrom befree-2016 NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_assertion wasGeneratedBy ECO_0000203 NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.
- befree-2016 importedOn "2016-02-19" NP478979.RAkVDTl19K2GAS4PY6bR-FQ5R4jEmQMN5ahhhELkfiyBs130_provenance.